Genome-wide maps of circulating miRNA biomarkers for Ulcerative Colitis

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Duttagupta, Radha ^a   DiRienzo, Sharon ^c   Jiang, Rong ^a   Bowers, Jessica ^b   Gollub, Jeremy ^a   Kao, Jessica ^a   Kearney, Keith ^c   Rudolph, David ^c   Dawany, Noor B ^d   Showe, Michael K ^d   Stamato, Tom ^c   Getts, Robert C ^b   Jones, Keith W ^a  

^a Thermo Fisher Scientific   (United States)

^b Genisphere LLC   (United States)

^c LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

^d WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; MICRORNA; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; CELLULAR IMMUNITY; CHROMOSOMAL LOCALIZATION; CHROMOSOME 20; CONTROLLED STUDY; CYTOSKELETON; DIAGNOSTIC ACCURACY; DISEASE MARKER; DISEASE PREDISPOSITION; FEMALE; GENE LOCUS; GENE REGULATORY NETWORK; GENE SEGREGATION; GENETIC ASSOCIATION; GENOME ANALYSIS; HUMAN; MALE; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; MICROARRAY ANALYSIS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; QUANTITATIVE ANALYSIS; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION REGULATION; ULCERATIVE COLITIS; VALIDATION PROCESS; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; INFLAMMATION; SUPPORT VECTOR MACHINE;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFLAMMATION; MICRORNAS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINES;

EID: 84857135660     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031241     Document Type: Article

References (49)

1. Loftus EV Jr, (2004) Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126: 1504-1517.
2. Nikolaus S, Schreiber S, (2007) Diagnostics of Inflammatory Bowel Disease. Gastroenterology 133: 1670-1689.
3. Beniwal P, Harrell L, (2010) The status of diagnostic markers for inflammatory bowel disease. Current Gastroenterology Reports 12: 479-484.
4. Roda G, Caponi A, Benevento M, Nanni P, Mezzanotte L, et al. (2010) New proteomic approaches for biomarker discovery in inflammatory bowel disease. Inflammatory Bowel Diseases 16: 1239-1246.
5. Fleischhacker M, Schmidt B, (2007) Circulating nucleic acids (CNAs) and cancer-A survey. Biochimica et Biophysica Acta- Reviews on Cancer 1775: 181-232.
6. Mandel P, Metais P, (1948) Les acides nucleiques du plasma sanguin chez l'homme. CR Acad SciParis 142: 241-243.
7. Kosaka N, Iguchi H, Ochiya T, (2010) Circulating microRNA in body fluid: A new potential biomarker for cancer diagnosis and prognosis. Cancer Science 101: 2087-2092.
8. Reid G, Kirschner MB, van Zandwijk N, (2010) Circulating microRNAs: Association with disease and potential use as biomarkers. Critical Reviews in Oncology/Hematology.
9. John B, Enright AJ, Aravin A, Tuschl T, Sander C, et al. (2004) Human MicroRNA targets. PLoS Biol 2: e363.
10. Bartel DP, (2004) MicroRNAs: Genomics, Biogenesis, Mechanism, and Function. Cell 116: 281-297.
11. Griffiths-Jones S, (2004) The microRNA Registry. Nucleic Acids Res 32: D109-111.
12. Griffiths-Jones S, (2010) miRBase: microRNA sequences and annotation. Current protocols in bioinformatics/editoral board, Andreas D Baxevanis [et al] Chapter 12: Unit 12.19.11-10.
13. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
14. Bartel DP, (2009) MicroRNAs: Target Recognition and Regulatory Functions. Cell 136: 215-233.
15. Garzon R, Calin GA, Croce CM, (2009) MicroRNAs in Cancer. Annu Rev Med 60: 167-179.
16. Pekow JR, Kwon JH, (2011) MicroRNAs in inflammatory bowel disease. Inflammatory Bowel Diseases.
17. McKenna LB, Schug J, Vourekas A, McKenna JB, Bramswig NC, et al. (2010) MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function. Gastroenterology 139: 1654-1664, 1664 e1651.
18. Danese S, (2011) Immune and nonimmune components orchestrate the pathogenesis of inflammatory bowel disease. American Journal of Physiology- Gastrointestinal and Liver Physiology 300: G716-G722.
19. Danese S, De La Motte C, Fiocchi C, (2004) Platelets in inflammatory bowel disease: Clinical, pathogenic, and therapeutic implications. American Journal of Gastroenterology 99: 938-945.
20. Danese S, Scaldaferri F, Papa A, Pola R, Sans M, et al. (2004) Platelets: new players in the mucosal scenario of inflammatory bowel disease. Eur Rev Med Pharmacol Sci 8: 193-198.
21. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
22. Benjamini YYD, (2001) The control of the false discovery rate in multiple testing under dependency. Annals of Statistics 29: 1165-1188.
23. Cortes CVV, (1995) Support-Vector Networks. Machine Learning 20: 273-297.
24. Landry P, Plante I, Ouellet DL, Perron MP, Rousseau G, et al. (2009) Existence of a microRNA pathway in anucleate platelets. Nature Structural and Molecular Biology.
25. Friedman RC, Farh KK, Burge CB, Bartel DP, (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105.
26. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, et al. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27: 91-105.
27. Vermeire S, Van Assche G, Rutgeerts P, (2006) Laboratory markers in IBD: Useful, magic, or unnecessary toys? Gut 55: 426-431.
28. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, et al. (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 3: e3694.
29. Bamias G, Cominelli F, (2007) Immunopathogenesis of inflammatory bowel disease: Current concepts. Current Opinion in Gastroenterology 23: 365-369.
30. Gnatenko DV, Dunn JJ, McCorkle SR, Weissmann D, Perrotta PL, et al. (2003) Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 101: 2285-2293.
31. Nagalla S, Shaw C, Kong X, Kondkar AA, Edelstein LC, et al. (2011) Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood 117: 5189-5197.
32. Wu F, Guo NJ, Tian H, Marohn M, Gearhart S, et al. (2011) Peripheral blood MicroRNAs distinguish active ulcerative colitis and Crohn's disease. Inflammatory Bowel Diseases 17: 241-250.
33. Clamp M, Fry B, Kamal M, Xie X, Cuff J, et al. (2007) Distinguishing protein-coding and noncoding genes in the human genome. Proc Natl Acad Sci U S A 104: 19428-19433.
34. Costello CM, Mah N, Häsler R, Rosenstiel P, Waetzig GH, et al. (2005) Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays. PLoS Medicine 2: 0771-0787.
35. Merrill AH Jr, Schmelz EM, Wang E, Dillehay DL, Rice LG, et al. (1997) Importance of sphingolipids and inhibitors of sphingolipid metabolism as components of animal diets. J Nutr 127: 830S-833S.
36. Schoedon G, Troppmair J, Adolf G, Huber C, Niederwieser A, (1986) Interferon-gamma enhances biosynthesis of pterins in peripheral blood mononuclear cells by induction of GTP-cyclohydrolase I activity. J Interferon Res 6: 697-703.
37. Wu F, Dassopoulos T, Cope L, Maitra A, Brant SR, et al. (2007) Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: Insights into distinctive pathogenesis. Inflammatory Bowel Diseases 13: 807-821.
38. Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG, et al. (2008) Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 456: 264-268.
39. Cadwell K, Liu JY, Brown SL, Miyoshi H, Loh J, et al. (2008) A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456: 259-263.
40. Lawrance IC, Fiocchi C, Chakravarti S, (2001) Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 10: 445-456.
41. Rybaczyk L, Rozmiarek A, Circle K, Grants I, Needleman B, et al. (2009) New bioinformatics approach to analyze gene expressions and signaling pathways reveals unique purine gene dysregulation profiles that distinguish between CD and UC. Inflammatory Bowel Diseases 15: 971-984.
42. Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, et al. (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10: 1470-1476.
43. Saunders MA, Liang H, Li WH, (2007) Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci U S A 104: 3300-3305.
44. Bao L, Zhou M, Wu L, Lu L, Goldowitz D, et al. (2007) PolymiRTS Database: Linking polymorphisms in microRNA target sites with complex traits. Nucleic Acids Research 35: D51-D54.
45. Boni V, Zarate R, Villa JC, Bandrés E, Gomez MA, et al. (2011) Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan. Pharmacogenomics Journal 11: 429-436.
46. Borel C, Antonarakis SE, (2008) Functional genetic variation of human miRNAs and phenotypic consequences. Mammalian Genome 19: 503-509.
47. Liu Z, Wei S, Ma H, Zhao M, Myers JN, et al. (2011) A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck. Carcinogenesis 32: 1668-1674.
48. Mishra PJ, Banerjee D, Bertino JR, (2008) MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics. Cell Cycle 7: 853-858.
49. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, et al. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 106: 9362-9367.